Professor Ruth Travis
Research groups
- Breast Cancer
- Cardiovascular disease
- Diet and nutrition
- Dietary Protein and Stroke Consortium
- Endogenous Hormones and Breast Cancer
- Endogenous Hormones, Nutritional Biomarkers and Prostate Cancer
- EPIC
- EPIC-Prostate
- Health and Lifestyle
- Prostate Cancer
- Shift work and disease
- Work and Social factors
- An investigation into cancer risk factors and mechanisms: a DPhil in molecular epidemiology
- An investigation into cancer risk factors and mechanisms: a DPhil in molecular epidemiology
- Assessing the links between shift work, sleep, circadian disruption and subsequent health
- Hormones, growth factors and health outcomes in middle and old age: a PheWAS approach in UK Biobank
- Prostate cancer epidemiology
- The molecular epidemiology of prostate cancer
Colleges
Websites
-
UK Biobank Prostate Cancer Epidemiology Consortium
Research Group
-
Endogenous Hormones and Prostate Cancer Collaborative Group
Research Group
-
Epidemiology of Shift Work and Disease
Research Group
Ruth Travis
BA, MSc, DPhil
Professor of Epidemiology and Senior Molecular Epidemiologist
- Cancer Epidemiology Unit
- MSc in Global Health Module Lead: Non-Communicable Diseases
Ruth Travis is a molecular epidemiologist, whose main research interests are the hormonal, lifestyle and genetic determinants of common non-communicable diseases, particularly cancer. Her work involves combining the resources of established large cohort studies and international consortia with study designs that take advantage of new technology, both in terms of ‘omics’ and electronic data linkage. She leads several projects for the Endogenous Hormones, Nutritional Biomarkers and Prostate Cancer Collaborative Group, and co-ordinates the UK Biobank Prostate Cancer Epidemiology Consortium, as well as studies on metabolomics and other biomarkers in relation to prostate cancer in the Europe-wide EPIC study. Ruth is Principal Investigator of a Health and Safety Executive-funded study of the effects of shift work and circadian disruption on chronic disease within the Million Women Study and EPIC-Oxford cohorts. She represents EPIC as a member of several international cancer genetics consortia (BPC3, PRACTICAL and Ellipse). Alongside research, Ruth co-ordinates the Unit’s public outreach activities with the aim of promoting greater public engagement with population health research, particularly in terms of raising awareness of and stimulating debate about epidemiological methods and the critical interpretation of findings. She joined the Cancer Epidemiology Unit in 2001 after studying Biological Anthropology (University of Cambridge, 1997-2000) and Epidemiology (LSHTM, 2000-01), and obtained a DPhil in Cancer Epidemiology (University of Oxford) in 2005.
Key publications
-
Gene-environment interactions in 7610 women with breast cancer: prospective evidence from the Million Women Study.
Journal article
Travis RC. et al, (2010), Lancet, 375, 2143 - 2151
-
Incidence of breast cancer and its subtypes in relation to individual and multiple low-penetrance genetic susceptibility loci.
Journal article
Reeves GK. et al, (2010), JAMA, 304, 426 - 434
-
Genetic variation in the lactase gene, dairy product intake and risk for prostate cancer in the European prospective investigation into cancer and nutrition.
Journal article
Travis RC. et al, (2013), Int J Cancer, 132, 1901 - 1910
-
CYP19A1 genetic variation in relation to prostate cancer risk and circulating sex hormone concentrations in men from the Breast and Prostate Cancer Cohort Consortium.
Journal article
Travis RC. et al, (2009), Cancer Epidemiol Biomarkers Prev, 18, 2734 - 2744
-
Melatonin and breast cancer: a prospective study.
Journal article
Travis RC. et al, (2004), J Natl Cancer Inst, 96, 475 - 482
Recent publications
-
Circulating free testosterone and risk of aggressive prostate cancer: prospective and Mendelian randomization analyses in international consortia.
Journal article
Watts EL. et al, (2022), Int J Cancer
-
Adiposity and risk of prostate cancer death: a prospective analysis in UK Biobank and meta-analysis of published studies.
Journal article
Perez-Cornago A. et al, (2022), BMC Med, 20
-
Circulating inflammatory biomarkers, adipokines and breast cancer risk-a case-control study nested within the EPIC cohort.
Journal article
Cairat M. et al, (2022), BMC Med, 20
-
Anti-cancer therapy is associated with long-term epigenomic changes in childhood cancer survivors.
Journal article
Robinson N. et al, (2022), Br J Cancer
-
Erratum: Recommended Definitions of Aggressive Prostate Cancer for Etiologic Epidemiologic Research (JNCI: J Natl Cancer Inst (2021) 113: 6 (727-734) DOI: 10.1093/jnci/djaa154)
Journal article
Hurwitz LM. et al, (2022), Journal of the National Cancer Institute, 114